Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of prrsv virus-like particle with immunogenicity and its preparation and application

An immunogenic, virus-like technology, used in antiviral agents, viruses/phages, viral antigen components, etc., can solve the problems of poor immune efficacy and strong virulence, and achieve high immunogenicity and immune protection rate. high effect

Active Publication Date: 2016-01-20
WUHAN CHOPPER BIOLOGY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These include classic PRRS inactivated vaccines and attenuated vaccines, HP-PRRS inactivated vaccines and attenuated vaccines, because live vaccines generally have the problem of strong virulence, and the main problem of inactivated vaccines is poor immune efficacy
There is no satisfactory vaccine in the world for the prevention of this disease. At present, the vaccine purchased by the Chinese government in large quantities is the highly pathogenic porcine reproductive and respiratory syndrome live vaccine (JXA1-R strain), which is produced by Highly pathogenic and strong virus strains are made by continuous passage of cells to weaken, and the vaccine also has the risk of returning to strong virulence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of prrsv virus-like particle with immunogenicity and its preparation and application
  • A kind of prrsv virus-like particle with immunogenicity and its preparation and application
  • A kind of prrsv virus-like particle with immunogenicity and its preparation and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] The construction of embodiment 1 baculovirus

[0077] According to the instructions of the TakaRMiniBESTViralRNA / DNA (code: DV819A) kit, the RNA of the Guangdong isolate of highly pathogenic porcine reproductive and respiratory syndrome virus was extracted, using oligo(dT) as a primer, and M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA) for reverse transcription to obtain cDNA.

[0078] Referring to the GenBank accession number: EU109503.1 gene sequence, the upstream primer 5'-GGATCCATGCCAAATAACAACGGCAAGC-3' and the downstream primer 5'-AAGCTTTCATGCTGAGGGTGATGCTGTG-3' with restriction sites were designed to amplify the N protein encoding PRRSVGD strain using cDNA as template The gene fragment, the amplified fragment was named PRRSV-N; it was recovered by double digestion with BamHI and HindIII, subcloned into the pFastBacDual vector (Invitrogen, Carlsbad, CA, USA) (abbreviated as pFBD) treated by the same restriction enzyme digestion, and pFBD was constructe...

Embodiment 2

[0082] Example 2 Expression of PRRSV VLPs in insect cells

[0083] SF9 insect cells were infected with the Bac-PRRSV-N-GP5 recombinant baculovirus expression vector at the MOI specified by the instructions of Invitrogen. After the recombinant virus infected SF9 cells for 72 hours, wash the cells twice with PBS, fix the cells with 80% (v / v) cold acetone for 20 minutes, wash three times with PBS, and add the mouse monoclonal antibody against PRRSVN protein or anti-PRRSV GP5 protein antibody (anti-PRRSV GP5 protein Rabbit polyclonal antibody) primary antibody (1:100) for 1 hour at 37°C, washed three times with PBS, FITC-labeled goat anti-mouse secondary antibody or goat anti-rabbit secondary antibody (1:500) for 1 hour at 37°C, washed three times with PBS, 50 % (v / v) glycerol for mounting and observing under a fluorescence microscope.

[0084] The antibody against PRRSV GP5 protein was used to detect the expression of the target protein in infected insect cells by immunofluoresc...

Embodiment 3

[0087] Embodiment 3 Immunogenicity of three kinds of PRRSV virus-like particles in mice

[0088] The mice were immunized with the crudely purified three kinds of virus-like particles to evaluate the immunogenicity of the virus-like particles. On the 1st and 14th day, the crudely purified three kinds of virus-like particles were injected subcutaneously with 1 μg / mouse, and the aluminum adjuvant The agent is an adjuvant (ratio of 3:7 to antigen). The control group was immunized with substances expressed by pFBD empty vector without exogenous gene and aluminum adjuvant. The mouse serum was collected 7, 14, 21, and 28 days after immunization, and the N antibody was measured with the PRRSVN antibody detection kit (Table 1) and the GP5 antibody was measured with the PRRSV GP5 antibody detection kit (Table 2). The results showed that The prepared Bac-N-GP5 virus-like particle vaccine immunization group had the highest positive serum N antibody and GP5 antibody on day 21 and day 28, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses PRRSV (porcine reproductive and respiratory syndrome virus) virus-like particles with immunogenicity as well as preparation and application thereof, and belongs to the technical field of agricultural veterinary biology. The preparation comprises the following steps: cloning coding sequences of N protein and GP5 protein of PRRSV into rod granules to obtain recombinant rod granules; infecting the recombined rod granules on insect cells, culturing the transfected insect cells to obtain recombinant baculovirus. The N protein and GP5 protein are expressed by adopting the recombinant baculovirus infected insect cells, protein with better steric configuration can be obtained, and PRRSV virus-like particles can be automatically assembled. The virus-like particles with high immunogenicity can be used for preparing vaccine for preventing infection of PRRSV. The PRRSV virus-like particles have high immune protective rate, can produce attacking protection on PRRSV virulent strain, can be safer and more effective, and do not have the risk of virulence return.

Description

technical field [0001] The invention belongs to the field of agricultural and veterinary biotechnology, and in particular relates to an immunogenic PRRSV virus-like particle and its preparation and application. Background technique [0002] Porcine reproductive and respiratory syndrome (Porcine Reproductive and Respiratory Syndrome, PRRS) is caused by porcine reproductive and respiratory syndrome virus (PRRSV), an infectious disease that seriously endangers the pig industry. The disease was first discovered in the United States in 1987. In 1991, the Central Veterinary Research Institute of the Netherlands determined that the pathogen of the disease was a new RNA virus and named it Lelystad virus. In 1996, Guo Baoqing and others isolated PRRSV from domestic suspected PRRS-infected pigs for the first time, thus confirming the existence of the disease in my country. In April 2006, highly pathogenic porcine reproductive and respiratory syndrome broke out in pig herds in my cou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N7/01A61K39/12A61P31/14
Inventor 杨雷漆世华王焕君李玉萍谢红玲温文生舒银辉朱薇冯钊
Owner WUHAN CHOPPER BIOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com